CME CLAIM: AOFAS/LLRS 2026 Specialty Day
Overview

Friday, March 6, 2026
Morial Convention Center
New Orleans, Louisiana

Chairs: Amgad M. Haleem Amin, MD, PhD, Elizabeth W. Hubbard, MD, and Paul E. Matuszewski, MD

Join AOFAS and LLRS for Specialty Day 2026!

Join AOFAS and the Limb Lengthening and Reconstruction Society (LLRS) for our Specialty Day collaboration on Friday, March 6, at AAOS Annual Meeting 2026 in New Orleans! The half-day education program offers an in-depth exploration of complex foot and ankle conditions and advanced correction techniques. Five focused sessions will cover avascular necrosis of the talus, arthritis in the young adult, rigid neuromuscular deformities, foot and ankle trauma, and diabetic foot.

Faculty Disclosures

Financial Disclosures

 

Michael Aynardi, MD (Speaker)

Arthrex, Inc.: Consultant, Self

Stryker Corporation: Consultant, Self

Zimmer Biomet Holdings, Inc.: Consultant, Self

 

Paul Matthew Balthrop, MD  (Speaker)

BoneSupport: Paid consultant

Synthes: Paid presenter or speaker

 

Christopher Chiodo, MD

American Orthopaedic Foot and Ankle Society: Fiduciary Officer, Self

BOSTON SCIENTIFIC CORPORATION: Stock, Self

JBJS: Fiduciary Officer, Self

Johnson & Johnson Health Care Systems Inc.: Stock, Self

Massachusetts Orthopaedic Association: Fiduciary Officer, Self

Merck & Co., Inc. : Stock, Self

Zimmer Biomet Holdings, Inc.: Stock, Self

 

Bryan Den Hartog. MD  (Speaker)

Smith and Nephew Orthopaedics: Consultant, Self

Stryker Corporation: Consultant, Self

Scott Ellis, MD  (Speaker)

American Orthopaedic Foot and Ankle Society: Fiduciary Officer, Self

Curvebeam: Consultant, Self

Elsevier Publishing: Consultant, Self

Extremis Robotics: Consultant, Self

Extremity Medical: Consultant, Self

Foot Innovate: Consultant, Self

HS2: Other Business Ownership, Self

Healio Orthopaedics: Other, Self

International Weightbearing CT Society: Fiduciary Officer, Self

JAASO: Other Business Ownership, Self

Medartis Inc.: Consultant, Self

Paragon 28, Inc.: Consultant, Self

Springer: Consultant, Self

Stryker: Consultant, Self

Vilex LLC: Consultant, Self

Wolters Kluwer: Other Intellectual Property, Self

 

Austin Fragomen, MD (Speaker)

Globus Medical, Inc.: Consultant, Self

 

David B. Frumberg , MD (Speaker)

Kyowa Kirin, Inc.: Type: Other Professional Activities

Orthofix Medical, Inc.: Type: Other Professional Activities

Ultragenyx Pharmaceutical Inc.: Type: Other Professional Activities

OrthoPediatrics Corp.: Type: Other Professional Activities

Limb Lengthening and Reconstruction Society, American Academy for Cerebral Palsy and Developmental Medicine: Type: Board of Directors or committee member Self

Tyler Gonzalez, MD, MBA  (Speaker)

DJO, LLC: Consultant, Self

Exactech, Inc.: Consultant, Self

Stryker: Consultant, Self

Treace Medical Concepts, Inc.: Consultant, Self

Vilex LLC: Consultant, Self

suprafusion technologies : Consultant, Self

 

Christopher Gross, MD

Alafair Biosciences,Inc.: Stock Option, Self

DJO, LLC: Consultant, Self

Flower Orthopedics Coporation: Consultant, Self

Fusion Orthopedics, LLC.: Consultant, Self

Orthofix Medical, Inc.: Consultant, Self

Paragon 28, Inc.: Consultant, Self

Stryker Corporation: Consultant, Self

 

Amgad Haleem Amin, MD, PhD (Planner, Moderator)

Extremity Medical: Consultant, Self

Orthofix Medical, Inc.: Consultant, Self

Stryker Corporation: Consultant, Self

Vilex LLC: Consultant, Self

Elizabeth Hubbard, MD (Planner, Moderator)

Orthofix Medical, Inc.: Consultant, Self

Todd Irwin, MD (Speaker)

GLW: Consultant, Self

Marrow Access Technologies: Consultant, Self

Medline Industries, Inc.: Consultant, Intellectual Property, Self

Paragon 28, Inc.: Consultant, Self

Paragon 28, Inc.: Other Intellectual Property, Self

Vilex LLC: Consultant, Intellectual Property, SelF

Jaeyoung Kim, MD (Speaker)

Nothing to Disclose


John Kwon, MD (Speaker)

DJO, LLC: Consultant, Self

Paragon 28, Inc.: Consultant, Self

restor3d, inc.: Consultant, Self

 

Paul Edward Matuszewski, MD (Planner, Moderator)

Stryker Corporation: Type: Other Professional Activities

Tidi Products: Type: Other Professional Activities

Globus Medical, Inc.: Type: Other Professional Activities

Austin Medical Ventures Inc: Type: Other Professional Activities

Bonesupport: Type: Other Professional Activities

LLRS: Type: Board of Directors or committee member Self


Jeremy McCormick, MD (Speaker)

Stryker Corporation: Consultant, Self


William McGarvey, MD  (Speaker)

Submitted on: 08/15/2024

Extremity Medical: Stock Option, Self

Stryker: Consultant, Self

Max Michalski, MD  (Speaker)

Extremity Medical: Consultant, Self

Extremity Medical: Other Intellectual Property, Self

Paragon 28, Inc.: Consultant, Self

 

Stephen Quinnan, MD  (Speaker)

Biocomposites Inc: Consultant, Self

Bone support: Consultant, Self

EDGe surgical: Stock Option, Self

Globus Medical, Inc.: Consultant, Self

Johnson & Johnson/Depuy Orthopedic: Consultant, Self

Orthofix Medical, Inc.: Consultant, Self

OsteoCentric Technologies, Inc.: Stock Option, Self

Reselute: Stock Option, Self

Royal Biologics: Consultant, Self

Smith and Nephew Orthopaedics: Consultant, Self

endeavor orthopedics: Consultant, Self

Veerabhadra Reddy, MD (Speaker)

Stryker Corporation: Consultant, Self

 
Anthony Riccio, MD  (Speaker)

Submitted on: 05/15/2024

OrthoPediatrics Corp.: Consultant, Self


Jason W Stoneback, MD (Speaker)

Validus Cellular Therapeutics: Type: Other Professional Activities

Ottobock: Type: Other Professional Activities

AQ Solutions: Type: Other Professional Activities

Exer AI: Type: Other Professional Activities

Balmoral: Type: Other Professional Activities

Revivo: Type: Other Professional Activities

Smith and Nephew: Type: Other Professional Activities

International Society for Prosthetics and Orthotics-Special Interest Group for Bone-Anchored Limbs Secretary: Type: Board of Directors or committee member Self

CME Overview and Information

Who Should Attend?

This educational program is designed for orthopaedic surgeons, physicians, and allied health practitioners in the field of orthopaedic foot and ankle surgery.


Educational Objectives

At the conclusion of AOFAS/LLRS Specialty Day learners should be able to:

  • Recognize and assess current data reflecting clinical trends, emerging surgical techniques, pre- and post-operative procedures, and technological innovations in orthopaedic foot and ankle surgery

  • Describe and apply current research in foot and ankle disorders to improve patient care

  • Identify ways to avoid potential complications in foot and ankle procedures

  • Incorporate knowledge of patient safety, outcomes, and evidence-based medicine into foot and ankle patient care


Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.


Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.


Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.


Disclosure of Conflict of Interest

Disclosure Statement
AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that "off label" uses of a drug or medical device may be described in its CME activities so long as the "off label" use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used "off label" if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members ("planners"), faculty, and appropriate staff disclose in writing to the learners all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author's participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best-available evidence.

 

CME Statement
The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AOFAS designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery's Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.
For more information on AOFAS accreditation and educational policies, visit the Program Overview page.
 
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
4 CME (MD) Credits
4 MOC Points
4 CME (PA/NP/RN) Credits
4 CEU (AT) Credits
4 CE (PT) Credits
4 CME (DPM) Credits
American Orthopaedic Foot & Ankle Society®
1515 E. Woodfield Road, Suite 850, Schaumburg, IL 60173
Phone: +1-847-698-4654
Copyright© 2024 All Rights Reserved
Powered By